Biomerica (BMRA) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -19.57% |
| Nov 30, 2025 | -24.57% |
| Aug 31, 2025 | 14.92% |
| May 31, 2025 | -58.03% |
| Feb 28, 2025 | -39.77% |
| Nov 30, 2024 | -3.71% |
| Aug 31, 2024 | -65.99% |
| May 31, 2024 | -100.16% |
| Feb 29, 2024 | -9.46% |
| Nov 30, 2023 | -12.47% |
| Aug 31, 2023 | -6.96% |
| May 31, 2023 | -4.56% |
| Feb 28, 2023 | -24.57% |
| Nov 30, 2022 | -31.95% |
| Aug 31, 2022 | -51.57% |
| May 31, 2022 | -28.47% |
| Feb 28, 2022 | 24.21% |
| Nov 30, 2021 | -35.10% |
| Aug 31, 2021 | -64.38% |
| May 31, 2021 | 4.07% |
| Feb 28, 2021 | -55.18% |
| Nov 30, 2020 | -71.88% |
| Aug 31, 2020 | -74.11% |
| May 31, 2020 | -30.26% |
| Feb 29, 2020 | -35.10% |
| Nov 30, 2019 | -10.76% |
| Aug 31, 2019 | -10.76% |
| May 31, 2019 | -43.10% |
| Feb 28, 2019 | -84.33% |
| Nov 30, 2018 | -10.76% |
| Aug 31, 2018 | -20.11% |
| May 31, 2018 | -58.49% |
| Feb 28, 2018 | -31.95% |
| Nov 30, 2017 | -24.57% |
| Aug 31, 2017 | -20.11% |
| May 31, 2017 | -43.10% |
| Feb 28, 2017 | -27.23% |
| Nov 30, 2016 | -21.67% |
| Aug 31, 2016 | -20.11% |
| May 31, 2016 | -78.26% |
| Feb 29, 2016 | -31.95% |
| Nov 30, 2015 | 17.79% |